Tag:comparative effectiveness

World Health Advocacy co-hosted the "Access to Rx Drugs:  What Every Patient Should Know" workshop held in Toronto, ON on September 21 & 22, 2009.  Elisabeth Fowler helped to moderate the workshop and also delivered the attached presentation, providing an overview of public engagement in HTA evaluations in other countries.

Read more...  

Presentation at the Canadian Agency for Drugs and Technologies in Health 2009 Symposium

Engaging Patients in HTA in Canada:  what's working and what needs to be done?

By:  Elisabeth Fowler, World Health Advocacy & Durhane Wong-Rieger, Institute for Optomizing Health Outcomes

Read more...  

Similar to other health policy initiatives, there is a growing movement to involve consumers in decisions affecting their treatment options. Access to treatments can be impacted by decisions made during a health technology assessment (HTA), i.e., the rigorous assessment of medical interventions such as drugs, vaccines, devices, materials, medical and surgical procedures and systems.

Read more...  
Powered by Tags for Joomla